Literature DB >> 6465977

Peritoneovenous shunt occlusion. Etiology, diagnosis, therapy.

H H LeVeen, I Vujic, N G d'Ovidio, R B Hutto.   

Abstract

Electronic pressure testing of every LeVeen valve has practically eliminated mechanical malfunction as a cause of shunt failure. Nonetheless, failures do occur and in a series of 240 cases, early or late shunt failure occurred in 29 patients. Thirty-five additional cases of failures were either referred by other physicians over a period of 6 years or information and x-rays were accumulated by direct contact. Shunt failure becomes manifest by a sudden reaccumulation of ascites in patients with a previously functioning shunt. In immediate failure, the ascites may fail to disappear after surgery or reaccumulate if removed. Ideally, caval clotting should be first excluded by x-ray visualization of the superior vena prior to injection of the shunt with contrast agent. Shuntograms are done with fine-bore needles. The venous pressure is also measured. The entry of contrast into the vena cava without pooling indicates a patent venous limb. The contrast will empty from the venous tubing with forceful inspiration if the entire system is patent. The venous tube will not clear if the valve or peritoneal collecting tubes are blocked. Only the valve and collecting tube need then be replaced if contrast enters the cava but does not leave the venous tubing. Occluded valves must not be flushed to restore patency since inflammatory exudate and cellular debris are erroneously identified as "fibrin flecks." Histology and culture are mandatory. Immediate and early failure are often caused by malposition of the venous tubing. Malplacements can often be diagnosed simply by chest x-rays. Intraoperative injection of methylene blue into the venous tubing establishes a satisfactory washout prior to wound closure. Fresh clots in the vena cava can be dissolved by the slow injection of streptokinase into the venous tubing. Other patent veins are chosen for access. Patients having repeat surgery after clotting must be heparinized to prevent a similar recurrence. Flushing blood clots from the cava can be fatal.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6465977      PMCID: PMC1250447          DOI: 10.1097/00000658-198408000-00016

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  17 in total

1.  SPONTANEOUS PERITONITIS AND BACTEREMIA IN LAENNEC'S CIRRHOSIS CAUSED BY ENTERIC ORGANISMS. A RELATIVELY COMMON BUT RARELY RECOGNIZED SYNDROME.

Authors:  H O CONN
Journal:  Ann Intern Med       Date:  1964-04       Impact factor: 25.391

2.  Patency of the peritoneovenous shunt.

Authors:  L F Rikkers; W A Fajman; J D Ansley; Y A Tarcan
Journal:  Surg Gynecol Obstet       Date:  1977-11

3.  The superior vena cava syndrome. A complication of the LeVeen shunt.

Authors:  G M Van Deventer; N Snyder; M Patterson
Journal:  JAMA       Date:  1979-10-12       Impact factor: 56.272

4.  Die-grown reinforced arterial grafts: observations on long-term animal grafts and clinical experience.

Authors:  C H Sparks
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

5.  Radionuclide assessment of LeVeen shunt patency.

Authors:  N Kirchmer; U Hart
Journal:  Ann Surg       Date:  1977-02       Impact factor: 12.969

6.  Assessment of peritoneojugular shunts by direct roentgenographic examination.

Authors:  E J Ring; E F Rosato
Journal:  Surg Gynecol Obstet       Date:  1979-01

7.  Sounding boards. The LeVeen shunt for ascites and hepatorenal syndrome.

Authors:  M Epstein
Journal:  N Engl J Med       Date:  1980-03-13       Impact factor: 91.245

8.  The importance of venous manometry during placement of trans-saphenous peritoneovenous shunts.

Authors:  L W Traverson; L DenBesten
Journal:  Surgery       Date:  1979-03       Impact factor: 3.982

9.  Lowering blood viscosity to overcome vascular resistance.

Authors:  H H LeVeen; M Ip; N Ahmed; T Mascardo; R B Guinto; G Falk; N D'Ovidio
Journal:  Surg Gynecol Obstet       Date:  1980-02

10.  Superior vena caval obstruction associated with long-term peritoneovenous shunting.

Authors:  F E Eckhauser; W E Strodel; J A Knol; J G Turcotte
Journal:  Ann Surg       Date:  1979-12       Impact factor: 12.969

View more
  8 in total

1.  Chylothorax secondary to obstruction of the superior vena cava: a complication of the LeVeen shunt.

Authors:  W H Warren; J S Altman; S A Gregory
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

2.  Persistent haemorrhagic ascites in generalised haemolymphangiomatosis: a therapeutic dilemma.

Authors:  B Smits; E Pullicino; A Nicolson; G A Court
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-18

3.  [Diagnosis of peritoneovenous shunt occlusion].

Authors:  W Klepetko; J Miholic; C Müller; M R Müller; C Schwarz; P Möschl
Journal:  Langenbecks Arch Chir       Date:  1987

Review 4.  [Peritoneovenous shunt in the treatment of therapy-refractory ascites].

Authors:  C A Eriksen; A Cuschieri
Journal:  Langenbecks Arch Chir       Date:  1988

5.  Coagulopathy post peritoneovenous shunt.

Authors:  H H LeVeen; M Ip; N Ahmed; R B Hutto; E G LeVeen
Journal:  Ann Surg       Date:  1987-03       Impact factor: 12.969

6.  The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis. A prospective study on 140 patients.

Authors:  C Smadja; D Franco
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

Review 7.  Role of surgical therapy in management of intractable ascites.

Authors:  J Elcheroth; C Vons; D Franco
Journal:  World J Surg       Date:  1994 Mar-Apr       Impact factor: 3.352

Review 8.  Symptomatic Fluid Drainage: Peritoneovenous Shunt Placement.

Authors:  Hooman Yarmohammadi; George I Getrajdman
Journal:  Semin Intervent Radiol       Date:  2017-12-14       Impact factor: 1.513

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.